NCT06947746View on ClinicalTrials.gov

HiSCs in the Treatment of Rheumatoid Arthritis

NANot yet recruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

June 1, 2026

Study Completion Date

April 1, 2027

Conditions
Rheumatoid Arthritis (RA)
Interventions
BIOLOGICAL

hiSCs

hiSCs are derived from human induced pluripotent stem cells and exhibit immunomodulatory properties.

Trial Locations (1)

200003

Shanghai ChangZheng hospital, Shanghai

All Listed Sponsors
lead

Shanghai Changzheng Hospital

OTHER

NCT06947746 - HiSCs in the Treatment of Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter